Arcutis Biotherapeutics
ARQT
NASDAQ
IPO2020
about ARQT
Arcutis Biotherapeutics is a biotechnology company focused on developing innovative topical therapies for the treatment of skin diseases, with its lead product being Scalpicin DC, a corticosteroid-free option for treating plaque psoriasis.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $22.50 | $25.54 | $22.00 | $2.35B | 7.94M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.13 | n/a | 39.72 | -17.93% | -19.49% | 0% |